DuPont De Nemours (DD) Q3 2026 earnings summary

Executive summary

• Q3 sales rose 4% YoY to $1.868B, with 5% organic growth; Operating EBITDA increased 8% to $469M, adjusted EPS was $2.09, and results exceeded guidance.

• FY26 guidance was raised again; full-year metrics were above the high end of medium-term targets.

Financial highlights

• Net sales were $1.868B versus $1.795B YoY; organic sales grew 5%, with a 1% currency headwind and flat portfolio impact.

• Operating EBITDA was $469M, up 8%; margin was 25.1%, up 80 bps reported and 90 bps versus prior-year pro forma.

• Adjusted EPS was $2.09, up 62% versus reported prior-year EPS and 31% versus prior-year pro forma.

• Continuing-operations income was $171M versus $102M; continuing-operations diluted EPS was $1.24 versus $0.70.

• Transaction-adjusted FCF was $341M, with 121% conversion; continuing-operations operating cash flow was $410M.

Outlook and guidance

• FY26 guidance: net sales ~$7.190B, Operating EBITDA ~$1.785B and adjusted EPS $7.47–$7.52; organic growth expected at ~4.5%.

• Midpoint guidance increases were $15M for sales, $25M for Operating EBITDA and $0.25 for adjusted EPS; full-year EPS growth is expected at 21%–22% versus prior-year pro forma.

• FY26 free cash flow conversion is expected at ~100%, ahead of the 90% target; pricing actions are expected to offset higher input costs.

• Q4 guidance: net sales ~$1.825B, Operating EBITDA ~$455M and adjusted EPS $1.90–$1.95; organic growth expected at ~8%, or ~6% excluding prior-year timing headwinds.

• Early 2027 expectations include end markets broadly similar to 2026, slight auto-build improvement, continued margin expansion and productivity gains; formal guidance due on the Q4 call.